These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36629356)

  • 1. Potential role of volatile organic compound breath testing in the Australasian colorectal cancer pathway.
    Gower H; Danielson K; Dennett APE; Deere J
    ANZ J Surg; 2023 May; 93(5):1159-1161. PubMed ID: 36629356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Volatile organic compounds in breath can serve as a non-invasive diagnostic biomarker for the detection of advanced adenomas and colorectal cancer.
    van Keulen KE; Jansen ME; Schrauwen RWM; Kolkman JJ; Siersema PD
    Aliment Pharmacol Ther; 2020 Feb; 51(3):334-346. PubMed ID: 31858615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breath testing as potential colorectal cancer screening tool.
    Amal H; Leja M; Funka K; Lasina I; Skapars R; Sivins A; Ancans G; Kikuste I; Vanags A; Tolmanis I; Kirsners A; Kupcinskas L; Haick H
    Int J Cancer; 2016 Jan; 138(1):229-36. PubMed ID: 26212114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary volatile organic compounds for colorectal cancer screening: A systematic review and meta-analysis.
    van Liere ELSA; van Dijk LJ; Bosch S; Vermeulen L; Heymans MW; Burchell GL; de Meij TGJ; Ramsoekh D; de Boer NKH
    Eur J Cancer; 2023 Jun; 186():69-82. PubMed ID: 37030079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Volatile organic compounds as new biomarkers for colorectal cancer: a review.
    Di Lena M; Porcelli F; Altomare DF
    Colorectal Dis; 2016 Jul; 18(7):654-63. PubMed ID: 26752703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Feasibility of volatile organic compound in breath analysis in the follow-up of colorectal cancer: A pilot study.
    Steenhuis EGM; Schoenaker IJH; de Groot JWB; Fiebrich HB; de Graaf JC; Brohet RM; van Dijk JD; van Westreenen HL; Siersema PD; de Vos Tot Nederveen Cappel WH
    Eur J Surg Oncol; 2020 Nov; 46(11):2068-2073. PubMed ID: 32778485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal volatile organic compounds for early detection of colorectal cancer: where are we now?
    Bosch S; Berkhout DJ; Ben Larbi I; de Meij TG; de Boer NK
    J Cancer Res Clin Oncol; 2019 Jan; 145(1):223-234. PubMed ID: 30554400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electronic nose can discriminate colorectal carcinoma and advanced adenomas by fecal volatile biomarker analysis: proof of principle study.
    de Meij TG; Larbi IB; van der Schee MP; Lentferink YE; Paff T; Terhaar Sive Droste JS; Mulder CJ; van Bodegraven AA; de Boer NK
    Int J Cancer; 2014 Mar; 134(5):1132-8. PubMed ID: 23959518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Curative Colorectal Cancer Surgery on Exhaled Volatile Organic Compounds and Potential Implications in Clinical Follow-up.
    Altomare DF; Di Lena M; Porcelli F; Travaglio E; Longobardi F; Tutino M; Depalma N; Tedesco G; Sardaro A; Memeo R; de Gennaro G
    Ann Surg; 2015 Nov; 262(5):862-6; discussion 866-7. PubMed ID: 26583677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of volatile organic compounds (VOCs) from exhaled breath as noninvasive methods for cancer diagnosis.
    Sun X; Shao K; Wang T
    Anal Bioanal Chem; 2016 Apr; 408(11):2759-80. PubMed ID: 26677028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breath based volatile organic compounds in the detection of breast, lung, and colorectal cancers: A systematic review.
    Oakley-Girvan I; Davis SW
    Cancer Biomark; 2017 Dec; 21(1):29-39. PubMed ID: 29060925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between cancer tissue derived and exhaled volatile organic compound from colorectal cancer patients. Preliminary results.
    De Vietro N; Aresta A; Rotelli MT; Zambonin C; Lippolis C; Picciariello A; Altomare DF
    J Pharm Biomed Anal; 2020 Feb; 180():113055. PubMed ID: 31877489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early detection and follow-up of colorectal neoplasia based on faecal volatile organic compounds.
    Bosch S; Bot R; Wicaksono A; Savelkoul E; van der Hulst R; Kuijvenhoven J; Stokkers P; Daulton E; Covington JA; de Meij TGJ; de Boer NKH
    Colorectal Dis; 2020 Sep; 22(9):1119-1129. PubMed ID: 32040880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary volatile organic compounds and faecal microbiome profiles in colorectal cancer.
    McFarlane M; Millard A; Hall H; Savage R; Constantinidou C; Arasaradnam R; Nwokolo C
    Colorectal Dis; 2019 Nov; 21(11):1259-1269. PubMed ID: 31282600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel non-invasive colorectal cancer diagnostic method: Volatile organic compounds as biomarkers.
    Alustiza M; Ripoll L; Canals A; Murcia O; Martínez-Roca A; García-Heredia A; Giner-Calabuig M; Jover R; Vidal L
    Clin Chim Acta; 2023 Mar; 542():117273. PubMed ID: 36863694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal Cancer Diagnosis through Breath Test Using a Portable Breath Analyzer-Preliminary Data.
    Picciariello A; Dezi A; Vincenti L; Spampinato MG; Zang W; Riahi P; Scott J; Sharma R; Fan X; Altomare DF
    Sensors (Basel); 2024 Apr; 24(7):. PubMed ID: 38610554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic review with meta-analysis: volatile organic compound analysis to improve faecal immunochemical testing in the detection of colorectal cancer.
    Chandrapalan S; Bosch S; Cubiella J; Guardiola J; Kimani P; Mulder C; Persaud K; de Meij TGJ; Altomare DF; Brenner H; de Boer NKH; Ricciardiello L; Arasaradnam RP
    Aliment Pharmacol Ther; 2021 Jul; 54(1):14-23. PubMed ID: 34004036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis by Volatile Organic Compounds in Exhaled Breath in Exhaled Breath from Patients with Gastric and Colorectal Cancers.
    Chung J; Akter S; Han S; Shin Y; Choi TG; Kang I; Kim SS
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of Four Distinct Volatile Indicators of Colorectal Cancer using Functionalized Titania Nanotubular Arrays.
    Bhattacharyya D; Kumar P; Mohanty SK; Smith YR; Misra M
    Sensors (Basel); 2017 Aug; 17(8):. PubMed ID: 28777343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Volatile organic compounds emitted from faeces as a biomarker for colorectal cancer.
    Bond A; Greenwood R; Lewis S; Corfe B; Sarkar S; O'Toole P; Rooney P; Burkitt M; Hold G; Probert C
    Aliment Pharmacol Ther; 2019 Apr; 49(8):1005-1012. PubMed ID: 30828825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.